130 related articles for article (PubMed ID: 9733769)
41. Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain.
Ständker L; Braulke T; Mark S; Mostafavi H; Meyer M; Höning S; Giménez-Gallego G; Forssmann WG
Biochemistry; 2000 May; 39(17):5082-8. PubMed ID: 10819974
[TBL] [Abstract][Full Text] [Related]
42. BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains.
Carrick FE; Forbes BE; Wallace JC
J Biol Chem; 2001 Jul; 276(29):27120-8. PubMed ID: 11356837
[TBL] [Abstract][Full Text] [Related]
43. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation.
Yan X; Forbes BE; McNeil KA; Baxter RC; Firth SM
J Biol Chem; 2004 Dec; 279(51):53232-40. PubMed ID: 15485880
[TBL] [Abstract][Full Text] [Related]
44. Solid-phase assay for insulin-like growth factor (IGF) binding to IGF-binding protein-3: application to the study of the effects of antibodies and heparin.
Koedam JA; Hoogerbrugge CM; van Buul-Offers SC; Van den Brande JL
J Endocrinol; 1997 Apr; 153(1):87-97. PubMed ID: 9135573
[TBL] [Abstract][Full Text] [Related]
45. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins.
Wong MS; Fong CC; Yang M
Biochim Biophys Acta; 1999 Jul; 1432(2):293-301. PubMed ID: 10407151
[TBL] [Abstract][Full Text] [Related]
46. Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions.
Lowman HB; Chen YM; Skelton NJ; Mortensen DL; Tomlinson EE; Sadick MD; Robinson IC; Clark RG
Biochemistry; 1998 Jun; 37(25):8870-8. PubMed ID: 9636028
[TBL] [Abstract][Full Text] [Related]
47. Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions.
Vajdos FF; Ultsch M; Schaffer ML; Deshayes KD; Liu J; Skelton NJ; de Vos AM
Biochemistry; 2001 Sep; 40(37):11022-9. PubMed ID: 11551198
[TBL] [Abstract][Full Text] [Related]
48. Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis.
Sakai K; Busby WH; Clarke JB; Clemmons DR
J Biol Chem; 2001 Mar; 276(12):8740-5. PubMed ID: 11121406
[TBL] [Abstract][Full Text] [Related]
49. Phosphorylation of rat insulin-like growth factor binding protein-1 does not affect its biological properties.
Peterkofsky B; Gosiewska A; Wilson S; Kim YR
Arch Biochem Biophys; 1998 Sep; 357(1):101-10. PubMed ID: 9721188
[TBL] [Abstract][Full Text] [Related]
50. Mapping of the insulin-like growth factor II binding site of the Type I insulin-like growth factor receptor by alanine scanning mutagenesis.
Sørensen H; Whittaker L; Hinrichsen J; Groth A; Whittaker J
FEBS Lett; 2004 May; 565(1-3):19-22. PubMed ID: 15135045
[TBL] [Abstract][Full Text] [Related]
51. Insulin-like growth factors (IGFs) and IGF binding protein-3 display disulfide isomerase activity.
Koedam JA; van den Brande JL
Biochem Biophys Res Commun; 1994 Feb; 198(3):1225-31. PubMed ID: 7509599
[TBL] [Abstract][Full Text] [Related]
52. IGF binding proteins and their functions.
Clemmons DR
Mol Reprod Dev; 1993 Aug; 35(4):368-74; discussion 374-5. PubMed ID: 7691098
[TBL] [Abstract][Full Text] [Related]
53. Insulin-like growth factor-I (IGF-I): solution properties and NMR chemical shift assignments near physiological pH.
Kuang Z; Yao S; McNeil KA; Forbes BE; Wallace JC; Norton RS
Growth Horm IGF Res; 2009 Jun; 19(3):226-31. PubMed ID: 19056307
[TBL] [Abstract][Full Text] [Related]
54. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3.
Campbell PG; Durham SK; Suwanichkul A; Hayes JD; Powell DR
Am J Physiol; 1998 Aug; 275(2):E321-31. PubMed ID: 9688635
[TBL] [Abstract][Full Text] [Related]
55. Solution structure and backbone dynamics of long-[Arg(3)]insulin-like growth factor-I.
Laajoki LG; Francis GL; Wallace JC; Carver JA; Keniry MA
J Biol Chem; 2000 Apr; 275(14):10009-15. PubMed ID: 10744677
[TBL] [Abstract][Full Text] [Related]
56. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I.
Schaffer ML; Deshayes K; Nakamura G; Sidhu S; Skelton NJ
Biochemistry; 2003 Aug; 42(31):9324-34. PubMed ID: 12899619
[TBL] [Abstract][Full Text] [Related]
57. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
58. Site-specific IGFBP-1 hyper-phosphorylation in fetal growth restriction: clinical and functional relevance.
Abu Shehab M; Khosravi J; Han VK; Shilton BH; Gupta MB
J Proteome Res; 2010 Apr; 9(4):1873-81. PubMed ID: 20143870
[TBL] [Abstract][Full Text] [Related]
59. Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate.
Kale AS; Liu F; Hintz RL; Baker BK; Brewer ED; Lee PD; Durham SK; Powell DR
Pediatr Nephrol; 1996 Aug; 10(4):467-73. PubMed ID: 8865245
[TBL] [Abstract][Full Text] [Related]
60. Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions.
Torres AM; Forbes BE; Aplin SE; Wallace JC; Francis GL; Norton RS
J Mol Biol; 1995 Apr; 248(2):385-401. PubMed ID: 7739048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
